|
Estimated cost of anticancer therapy directed by comprehensive genomic profiling (CGP) in a single-center study. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; Novartis; Sequenom; Trovagene |
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Fujifilm; Novartis; Piqur; Plexxikon; Roche; Symphony Evolution; Trovagene |
Other Relationship - Bio-Rad |
|
|
|
Stock and Other Ownership Interests - Novartis |
|
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Other Relationship - Analysis Group |
|
|
No Relationships to Disclose |